Xbrane Biopharma AB
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD (NCT03805100) | Xbrane Biopharma AB | 2019-04-19 |
Track Xbrane Biopharma AB automatically
Every clearance here is in the API, with alerts when new ones post.